Teclistamab
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Teclistamab, covering 2025-03-19 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment [Phase 1, Phase 2]